Associations - NTRK2 fusion

NTRK2 fusion NTRK2 fusion	Sarcoma Sarcoma	larotrectinib Sensitive: A1 - Approval
NTRK2 fusion NTRK2 fusion	Solid Tumor Solid Tumor	larotrectinib Sensitive: A1 - Approval
NTRK2 fusion NTRK2 fusion	Solid Tumor Solid Tumor	entrectinib Sensitive: A1 - Approval
NTRK2 fusion NTRK2 fusion	Small Intestinal Carcinoma Small Intestinal Carcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Follicular Carcinoma Thyroid Gland Follicular Carcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Hurthle Cell Carcinoma Thyroid Gland Hurthle Cell Carcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Follicular Carcinoma Thyroid Gland Follicular Carcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastrointestinal Stromal Tumor GIST	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Breast Cancer Breast Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Peritoneal Cancer Peritoneal Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Peritoneal Cancer Peritoneal Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Fallopian Tube Cancer Fallopian Tube Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Fallopian Tube Cancer Fallopian Tube Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Sarcoma Sarcoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Endometrial Cancer Endometrial Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Papillary Carcinoma Thyroid Gland Papillary Carcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Small Intestinal Carcinoma Small Intestinal Carcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Pancreatic Cancer Pancreatic Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Pancreatic Cancer Pancreatic Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastrointestinal Stromal Tumor GIST	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Non Small Cell Lung Cancer NSCLC	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Papillary Carcinoma Thyroid Gland Papillary Carcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Soft Tissue Sarcoma Soft Tissue Sarcoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Esophageal Cancer Esophageal Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Esophageal Cancer Esophageal Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastroesophageal Junction Adenocarcinoma Gastroesophageal Junction Adenocarcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Cervical Cancer Cervical Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Cervical Cancer Cervical Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Non Small Cell Lung Cancer NSCLC	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Soft Tissue Sarcoma Soft Tissue Sarcoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Biliary Tract Cancer Biliary Tract Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Biliary Tract Cancer Biliary Tract Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Colorectal Cancer CRC	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Breast Cancer Breast Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Melanoma Melanoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Hepatocellular Cancer HCC	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Hepatocellular Cancer HCC	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Ovarian Cancer Ovarian Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Ovarian Cancer Ovarian Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Colorectal Cancer CRC	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma Thyroid Gland Anaplastic Carcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Anaplastic Carcinoma Thyroid Gland Anaplastic Carcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Salivary Gland Cancer Salivary Gland Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Endometrial Cancer Endometrial Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Salivary Gland Cancer Salivary Gland Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastric Cancer Gastric Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Gastric Cancer Gastric Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Thyroid Gland Hurthle Cell Carcinoma Thyroid Gland Hurthle Cell Carcinoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Cutaneous Melanoma Cutaneous Melanoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Cutaneous Melanoma Cutaneous Melanoma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Glioma Glioma	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Rectal Cancer Rectal Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Rectal Cancer Rectal Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Glioma Glioma	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Vulvar Cancer Vulvar Cancer	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Vulvar Cancer Vulvar Cancer	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Glioblastoma GBM	larotrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Glioblastoma GBM	entrectinib Sensitive: A2 - Guideline
NTRK2 fusion NTRK2 fusion	Solid Tumor Solid Tumor	TPX-0005 Sensitive: B - Late Trials
NTRK2 fusion NTRK2 fusion	Lung Cancer Lung Cancer	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Gastrointestinal Cancer Gastrointestinal Cancer	entrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Small Cell Lung Cancer Small Cell Lung Cancer	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Fibrosarcoma Fibrosarcoma	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Cholangiocarcinoma Cholangiocarcinoma	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Osteosarcoma Osteosarcoma	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Thyroid Gland Carcinoma Thyroid Gland Carcinoma	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Cholangiocarcinoma Cholangiocarcinoma	entrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Colon Cancer Colon Cancer	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	CNS Tumor CNS Tumor	larotrectinib Sensitive: C1 - Off-label
NTRK2 fusion NTRK2 fusion	Colorectal Cancer CRC	Immunotherapy Sensitive: C3 – Early Trials
NTRK2 fusion NTRK2 fusion	Glioma Glioma	trametinib + entrectinib Sensitive: D – Preclinical
NTRK2 fusion NTRK2 fusion	Glioma Glioma	entrectinib + abemaciclib Sensitive: D – Preclinical
NTRK2 fusion NTRK2 fusion	Solid Tumor Solid Tumor	SIM1803-1A Sensitive: D – Preclinical